Prosthesis–patient mismatch after aortic valve replacement predominantly affects patients with preexisting left ventricular dysfunction: Effect on survival,

Slides:



Advertisements
Similar presentations
W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P
Advertisements

Tomislav Mihaljevic, MD, Edward R
Society of Thoracic Surgeons 2008 cardiac risk models predict in-hospital mortality of heart valve surgery in a Chinese population: A multicenter study 
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Manuel J. Antunes, MD, PhD, DSc 
Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,
Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter study  Vincent Chan,
by Alexander Kulik, Ian G. Burwash, Varun Kapila, Thierry G
Renal function and outcome after heart transplantation
Left ventricular dysfunction after mitral valve repair—the fallacy of “normal” preoperative myocardial function  Eduard Quintana, MD, Rakesh M. Suri,
Off-pump coronary artery bypass grafting does not preserve renal function better than on-pump coronary artery bypass grafting: Results of a case-matched.
Postoperative tricuspid regurgitation after adult congenital heart surgery is associated with adverse clinical outcomes  Matthew J. Lewis, MD, MPH, Jonathan.
Increased late mortality after coronary artery bypass surgery complicated by isolated new-onset atrial fibrillation: A comprehensive propensity-matched.
Moderate chronic kidney disease and left ventricular hypertrophy after aortic valve replacement for aortic valve stenosis  Umberto Benedetto, MD, Giovanni.
Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: A propensity score analysis  Christophe de Meester, MS, Agnès Pasquet,
Prospective randomized comparison of CarboMedics and St
Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery  Sun Kyun Ro, MD, Joon Bum Kim, MD, Sung Ho Jung, MD,
Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society.
Prolonged QTc affects short-term and long-term outcomes in patients with normal left ventricular function undergoing cardiac surgery  Nattachai Anantasit,
Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age  Torsten Christ,
Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G
Neurologic complications after off-pump coronary artery bypass grafting with and without aortic manipulation: Meta-analysis of 11,398 cases from 8 studies 
Eight-year results after aortic valve replacement with the CryoLife-O’Brien Stentless Aortic Porcine Bioprosthesis  Ivo Martinovic, MD, Ibrahim Farah,
Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery  Vincent Chan, MD, MPH, Thierry.
Clinical and echocardiographic outcomes after repair of mitral valve bileaflet prolapse due to myxomatous disease  Vincent Chan, MD, MPH, Marc Ruel, MD,
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
Transfusion of sex-mismatched and non–leukocyte-depleted red blood cells in cardiac surgery increases mortality  Henrik Bjursten, MD, PhD, Alain Dardashti,
A new paradigm for obtaining marketing approval for pediatric-sized prosthetic heart valves  Ajit P. Yoganathan, PhD, Mark Fogel, MD, Susan Gamble, BS,
The variability of the mitral valve anatomy and terminology
Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.
Alexander Kulik, MD, Manal Al-Saigh, MD, Vincent Chan, MD, Roy G
Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement  Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,
W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P
Transcatheter aortic valve replacement in intermediate-risk patients
Two internal thoracic artery grafts are better than one
Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation  Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.
Clinical evaluation of functional mitral stenosis after mitral valve repair for degenerative disease: Potential affect on surgical strategy  Thierry G.
Joshua M. Rosenblum, MD, PhD, Bradley G. Leshnower, MD, Rena C
Effect of the prosthesis–patient mismatch on long-term clinical outcomes after isolated aortic valve replacement for aortic stenosis: A prospective observational.
Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies  J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,
Torsten Doenst, MD, PhD, Markus Richter, MD 
Bahaaldin Alsoufi, MD, Cedric Manlhiot, BSc, Brian W
Open thoracoabdominal aortic repair for chronic type B dissection
Transient right ventricular dysfunction caused by retractor during lower hemisternotomy mitral valve repair in a patient with pectus excavatum  Homare.
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Replicating the success of mitral valve repair in the aortic valve
The CarboMedics supra-annular Top Hat valve improves long-term left ventricular mass regression  Victor X. Mosquera, MD, PhD, Alberto Bouzas-Mosquera,
Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation  Aaron Martin, MD, Michael.
Biomaterials for heart valve replacement: Conjectures and refutations
Turki B. Albacker, MD, MSc, Eugene H. Blackstone, MD, Sarah J
Hans-Joachim Schäfers, MD 
Constantine L. Athanasuleas, MD, FACC 
Defining Patient-Prosthesis Mismatch and Its Effect on Survival in Patients With Impaired Ejection Fraction  David A. Cotoni, DO, Robert T. Palac, MD,
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone?  Juan A. Crestanello, MD  The Journal of.
The future of cardiac surgery training: A survival guide
Influence of prosthesis–patient mismatch on exercise-induced arrhythmias: A further aspect after aortic valve replacement  Vito Antonio Mannacio, MD,
Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable  Craig M. Jarrett,
Commentary: When a choice is not an echo
Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement  Todd M. Dewey,
Late incidence and determinants of stroke after aortic and mitral valve replacement  Marc Ruel, MD, MPH, Roy G Masters, MD, Fraser D Rubens, MD, Pierre.
Pasquale Totaro, MD, Vincenzo Argano, MD 
YingXing Wu, MD, Gary L. Grunkemeier, PhD, Albert Starr, MD 
National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements  Abby J. Isaacs, MS, Jeffrey Shuhaiber,
Influence of Prosthesis–Patient Mismatch on Diastolic Heart Failure After Aortic Valve Replacement  Shahab Nozohoor, MD, Johan Nilsson, MD, PhD, Carsten.
Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement?  F. Dagenais, MD, P. Cartier, MD, P. Voisine,
Preoperative characteristics and surgical outcomes of acute intramural hematoma involving the ascending aorta: A propensity score–matched analysis  Akihito.
Paul Philipp Heinisch, MD, Thierry Carrel, MD 
Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?  Andrew W. ElBardissi, MD, MPH, Daniel.
Presentation transcript:

Prosthesis–patient mismatch after aortic valve replacement predominantly affects patients with preexisting left ventricular dysfunction: Effect on survival, freedom from heart failure, and left ventricular mass regression  Marc Ruel, MD, MPH, Hussam Al-Faleh, MD, Alexander Kulik, MD, Kwan L. Chan, MD, Thierry G. Mesana, MD, PhD, Ian G. Burwash, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 131, Issue 5, Pages 1036-1044 (May 2006) DOI: 10.1016/j.jtcvs.2005.10.028 Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Crude (A) and adjusted (B) survival after aortic valve replacement, by left ventricular function and prosthesis–patient mismatch. Patients with the combination of impaired preoperative left ventricular function and postoperative prosthesis–patient mismatch had lower survival after aortic valve replacement, despite adjustment for age, other risk factors for mortality after AVR,2 and baseline patient characteristics. *Crude and adjusted hazard ratios are in comparison to the “Normal LV; No PPM” group. CI, Confidence interval; HR, hazard ratio; LV, left ventricle; PPM, prosthesis–patient mismatch. The Journal of Thoracic and Cardiovascular Surgery 2006 131, 1036-1044DOI: (10.1016/j.jtcvs.2005.10.028) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Effect of preoperative left ventricular function and prosthesis–patient mismatch on the cumulative incidence of heart failure symptoms or death related to heart failure at 3 years after aortic valve replacement. Nonitalic percentages, bars, and odds ratios refer to the occurrence of either heart failure symptoms or death. Italic percentages in parentheses indicate heart failure death. Odds ratios are in comparison to the “Normal LV; No PPM” group and are adjusted for risk factors of decreased freedom from heart failure after AVR2 and for baseline patient characteristics. Patients with the combination of impaired preoperative left ventricular function and postoperative prosthesis–patient mismatch had a lower freedom from heart failure despite adjustment for confounding factors. CI, Confidence interval; LV, left ventricle; PPM, prosthesis–patient mismatch. The Journal of Thoracic and Cardiovascular Surgery 2006 131, 1036-1044DOI: (10.1016/j.jtcvs.2005.10.028) Copyright © 2006 The American Association for Thoracic Surgery Terms and Conditions